Inducible overexpression of a toxic protein by an adenovirus vector with a tetracycline-regulatable expression cassette

被引:100
作者
Massie, B
Couture, F
Lamoureux, L
Mosser, DD
Guilbault, C
Jolicoeur, P
Bélanger, F
Langelier, Y
机构
[1] Natl Res Council Canada, Biotechnol Res Inst, Quebec City, PQ H4P 2R2, Canada
[2] Inst Canc Montreal, Ctr Rech Louis Charles Simard, Quebec City, PQ H2L 4M1, Canada
关键词
D O I
10.1128/JVI.72.3.2289-2296.1998
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We have constructed two new adenovirus expression cassettes that expand both the range of genes which can be expressed with adenovirus vectors (AdV) and the range of cells in which high-level expression can be attained. Ey inclusion of a tetracycline-regulated promoter in the transfer vector pAdTR5, it is now possible to generate recombinant adenoviruses expressing proteins that are either cytotoxic or that interfere with adenovirus replication. We have used this strategy to generate a recombinant adenovirus encoding a deletion in the R1 subunit [R1(Delta 2-357)] of the herpes simplex virus type 2 ribonucleotide reductase. Cell lines expressing the tetracycline-regulated transactivator (tTA) from an integrated vector or following infection with an AdV expressing tTA are able to produce Delta R1 protein at a level approaching 10% total cell protein (TCP) when infected with Ad5TR5 Delta R1 before they subsequently die. To our knowledge, this is the first report of the overexpression of a toxic gene product with AdV. We have also constructed a new constitutive adenovirus expression cassette based on an optimized cytomegalovirus immediate-early promoter-enhancer that allows the expression of recombinant proteins at a level greater than 20% TCP in nonpermissive cell lines. Together, these new expression cassettes significantly improve the utility of the adenovirus system for high-level expression of recombinant proteins in animal cells and wilt undoubtedly find useful applications in gene therapy.
引用
收藏
页码:2289 / 2296
页数:8
相关论文
共 41 条
  • [1] ACSADI G, 1995, J MOL MED, V73, P165
  • [2] A DIFFERENTIAL EFFICIENCY OF ADENOVIRUS-MEDIATED IN-VIVO GENE-TRANSFER INTO SKELETAL-MUSCLE CELLS OF DIFFERENT MATURITY
    ACSADI, G
    JANI, A
    MASSIE, B
    SIMONEAU, M
    HOLLAND, P
    BLASCHUK, K
    KARPATI, G
    [J]. HUMAN MOLECULAR GENETICS, 1994, 3 (04) : 579 - 584
  • [3] SITE-SPECIFIC RECOMBINATION MEDIATED BY AN ADENOVIRUS VECTOR EXPRESSING THE CRE RECOMBINASE PROTEIN - A MOLECULAR SWITCH FOR CONTROL OF GENE-EXPRESSION
    ANTON, M
    GRAHAM, FL
    [J]. JOURNAL OF VIROLOGY, 1995, 69 (08) : 4600 - 4606
  • [4] BERKNER KL, 1992, CURR TOP MICROBIOL, V158, P39
  • [5] BERKNER KL, 1988, BIOTECHNIQUES, V6, P616
  • [6] Construction of a double recombinant adenovirus vector expressing a heterodimeric cytokine: In vitro and in vivo production of biologically active interleukin-12
    Bramson, J
    Hitt, M
    Gallichan, WS
    Rosenthal, KL
    Gauldie, J
    Graham, FL
    [J]. HUMAN GENE THERAPY, 1996, 7 (03) : 333 - 342
  • [7] High-level tissue-specific expression of functional human factor VIII in mice
    Connelly, S
    Gardner, JM
    McClelland, A
    Kaleko, M
    [J]. HUMAN GENE THERAPY, 1996, 7 (02) : 183 - 195
  • [8] IMPROVED FACS-GAL - FLOW CYTOMETRIC ANALYSIS AND SORTING OF VIABLE EUKARYOTIC CELLS EXPRESSING REPORTER GENE CONSTRUCTS
    FIERING, SN
    ROEDERER, M
    NOLAN, GP
    MICKLEM, DR
    PARKS, DR
    HERZENBERG, LA
    [J]. CYTOMETRY, 1991, 12 (04): : 291 - 301
  • [9] SCALE-UP OF THE ADENOVIRUS EXPRESSION SYSTEM FOR THE PRODUCTION OF RECOMBINANT PROTEIN IN HUMAN 293S CELLS
    GARNIER, A
    COTE, J
    NADEAU, I
    KAMEN, A
    MASSIE, B
    [J]. CYTOTECHNOLOGY, 1994, 15 (1-3) : 145 - 155
  • [10] Gluzman Y., 1982, EUKARYOTIC VIRAL VEC, P187